{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "marketState": "PRE", "messageBoardId": "finmb_136941170", "regularMarketChangePercent": 0.63492, "regularMarketPrice": 6.34, "exchange": "NCM", "shortName": "GRI Bio, Inc.", "longName": "GRI Bio, Inc.", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "firstTradeDateMilliseconds": 1612967400000, "priceHint": 2, "regularMarketChange": 0.03999996, "regularMarketTime": 1684180794, "regularMarketDayHigh": 6.505, "regularMarketDayRange": "6.34 - 6.505", "regularMarketDayLow": 6.34, "regularMarketVolume": 5373, "regularMarketPreviousClose": 6.3, "bid": 0.0, "ask": 0.0, "bidSize": 9, "askSize": 9, "fullExchangeName": "NasdaqCM", "financialCurrency": "USD", "regularMarketOpen": 6.38, "averageDailyVolume3Month": 45189, "averageDailyVolume10Day": 29990, "fiftyTwoWeekLowChange": 0.8500004, "fiftyTwoWeekLowChangePercent": 0.15482703, "fiftyTwoWeekRange": "5.49 - 36.9", "fiftyTwoWeekHighChange": -30.560001, "fiftyTwoWeekHighChangePercent": -0.8281843, "fiftyTwoWeekLow": 5.49, "fiftyTwoWeekHigh": 36.9, "earningsTimestamp": 1677241800, "earningsTimestampStart": 1684234740, "earningsTimestampEnd": 1685102400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.02, "sharesOutstanding": 2957090, "bookValue": -0.061, "fiftyDayAverage": 10.7739, "fiftyDayAverageChange": -4.4339, "fiftyDayAverageChangePercent": -0.41154084, "twoHundredDayAverage": 10.527825, "twoHundredDayAverageChange": -4.187825, "twoHundredDayAverageChangePercent": -0.39778635, "marketCap": 19937082, "priceToBook": -103.934425, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Vallon Pharmaceuticals, Inc.", "nameChangeDate": "2023-05-15", "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "displayName": "GRI Bio", "symbol": "GRI"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "2223 Avenida DE LA Playa", "address2": "Suite 208", "city": "La Jolla", "state": "CA", "zip": "92037", "country": "United States", "phone": "619 400 1171", "website": "https://www.gribio.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "GRI Bio, Inc., a development stage biotech company, develops Natural Killer T (NKT) cell-based therapies for liver disease and autoimmunity. Its program includes GRI-0621, an inhibitor of type 1 NKT cells that develops as an oral therapeutic for liver disease. GRI Bio, Inc. was formerly know as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in La Jolla, California.", "fullTimeEmployees": 1, "companyOfficers": [{"maxAge": 1, "name": "Dr. Marc  Hertz Ph.D.", "title": "Co-Founder, CEO, Pres & Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Vipin  Kumar Ph.D.", "title": "Co-Founder, Chief Scientific Officer and Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Leanne M. Kelly", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1977, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Albert  Agro Ph.d.", "age": 57, "title": "Sr. VP of Clinical Devel.", "yearBorn": 1965, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}